Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-24 @ 6:51 PM
NCT ID: NCT07275957
Eligibility Criteria: Inclusion Criteria: * Women aged 30 to 65 years. * Previous diagnosis of breast cancer (stages I-III) confirmed by medical records. * Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment. * Absence of active cancer or evidence of recurrence. * Medical clearance to perform physical exercise. * Willingness to participate in dietary and/or exercise interventions for 12 weeks. * Ability to attend evaluation and intervention sessions and comply with study procedures. * Signed written informed consent. Exclusion Criteria: * Active cancer, metastasis, or ongoing chemotherapy or radiotherapy. * Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise. * Musculoskeletal or neurological conditions limiting participation in physical activity. * Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention. * Current participation in another clinical trial or structured lifestyle intervention. * Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period. * Pregnancy, breastfeeding, or intention to become pregnant during the study. * Inability to comply with the intervention schedule or follow-up assessments.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 30 Years
Maximum Age: 65 Years
Study: NCT07275957
Study Brief:
Protocol Section: NCT07275957